Cargando…
RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells
INTRODUCTION: Paclitaxel is a widely used drug in the treatment of patients with locally advanced and metastatic breast cancer. However, only a small portion of patients have a complete response to paclitaxel-based chemotherapy, and many patients are resistant. Strategies that increase sensitivity a...
Autores principales: | Bauer, Joshua A, Ye, Fei, Marshall, Clayton B, Lehmann, Brian D, Pendleton, Christopher S, Shyr, Yu, Arteaga, Carlos L, Pietenpol, Jennifer A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917036/ https://www.ncbi.nlm.nih.gov/pubmed/20576088 http://dx.doi.org/10.1186/bcr2595 |
Ejemplares similares
-
Analysis of high-throughput RNAi screening data in identifying genes mediating sensitivity to chemotherapeutic drugs: statistical approaches and perspectives
por: Ye, Fei, et al.
Publicado: (2012) -
RNA Interference (RNAi) Screening in Drosophila
por: Heigwer, Florian, et al.
Publicado: (2018) -
Comparative Study of Exome Copy Number Variation Estimation Tools Using Array Comparative Genomic Hybridization as Control
por: Guo, Yan, et al.
Publicado: (2013) -
Corrigendum to “Comparative Study of Exome Copy Number Variation Estimation Tools Using Array Comparative Genomic Hybridization as Control”
por: Guo, Yan, et al.
Publicado: (2017) -
A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin Treatments
por: Mohni, Kareem N., et al.
Publicado: (2015)